Arch Therapeutics, Inc. Annual Depreciation in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Arch Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2012 to 2023.
  • Arch Therapeutics, Inc. Depreciation for the quarter ending December 31, 2023 was $650.000, a 1.96% decline year-over-year.
  • Arch Therapeutics, Inc. Depreciation for the twelve months ending December 31, 2023 was $1.95K, a 36.2% decline year-over-year.
  • Arch Therapeutics, Inc. annual Depreciation for 2023 was $1.97K, a 38.5% decline from 2022.
  • Arch Therapeutics, Inc. annual Depreciation for 2022 was $3.2K, a 23.5% increase from 2021.
  • Arch Therapeutics, Inc. annual Depreciation for 2021 was $2.59K, a 62.6% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.97K -$1.23K -38.5% Oct 1, 2022 Sep 30, 2023 10-K 2024-02-15
2022 $3.2K +$609 +23.5% Oct 1, 2021 Sep 30, 2022 10-K 2024-02-15
2021 $2.59K -$4.34K -62.6% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-28
2020 $6.93K -$1.31K -15.9% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-17
2019 $8.24K +$2.9K +54.2% Oct 1, 2018 Sep 30, 2019 10-K 2020-12-11
2018 $5.34K +$3.84K +257% Oct 1, 2017 Sep 30, 2018 10-K 2019-11-19
2017 $1.5K +$1.5K Oct 1, 2016 Sep 30, 2017 10-K 2018-12-18
2016 $0 $0 Oct 1, 2015 Sep 30, 2016 10-K 2017-11-15
2015 $0 -$322 -100% Oct 1, 2014 Sep 30, 2015 10-K 2015-12-11
2014 $322 -$264 -45.1% Oct 1, 2013 Sep 30, 2014 10-K 2015-12-11
2013 $586 -$2.79K -82.6% Oct 1, 2012 Sep 30, 2013 10-K 2014-12-12
2012 $3.37K Oct 1, 2011 Sep 30, 2012 10-K/A 2014-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.